Drug intelligence / Profile preview

QRH-882260

Development stage
Phase 1
Lead developer
University of Michigan
Modality
Small Molecules, Peptide-Drug Conjugates → Peptide Conjugates → Peptides, Recombinant Proteins and Enzymes
Administration
Oral, Topical, Intraductal
01

Overview

QRH-882260 is an orally bioavailable, fluorescent-labeled heptapeptide imaging agent. It consists of a seven-amino acid peptide conjugated to the near-infrared fluorophore cyanine 5 (Cy5). The peptide specifically binds to the tumor-associated antigen epidermal growth factor receptor (EGFR), which is overexpressed in various neoplasms. By targeting EGFR, QRH-882260 enables real-time fluorescence imaging of neoplastic tissues during endoscopic procedures, such as colonoscopy and ERCP for biliary disorders. Its primary use has been as a diagnostic dye for detecting and delineating cancerous or dysplastic lesions in the digestive tract[1][2][4][7].

Other names
imaging agent QRH-882260 heptapeptide
02

Targets

Beyond the preview

Go deeper on QRH-882260.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on QRH-882260.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call